Metformin, macrophage dysfunction and atherosclerosis

X Feng, W Chen, X Ni, PJ Little, S Xu, L Tang… - Frontiers in …, 2021 - frontiersin.org
Metformin is one of the most widely prescribed hypoglycemic drugs and has the potential to
treat many diseases. More and more evidence shows that metformin can regulate the …

Phagocytosis, degranulation and extracellular traps release by neutrophils—the current knowledge, pharmacological modulation and future prospects

B Gierlikowska, A Stachura, W Gierlikowski… - Frontiers in …, 2021 - frontiersin.org
Neutrophils are crucial elements of innate immune system, which assure host defense via a
range of effector functions, such as phagocytosis, degranulation, and NET formation. The …

The clinical characterization of the patient with primary psychosis aimed at personalization of management

M Maj, J van Os, M De Hert, W Gaebel… - World …, 2021 - Wiley Online Library
The current management of patients with primary psychosis worldwide is often remarkably
stereotyped. In almost all cases an antipsychotic medication is prescribed, with second …

Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence

T Salvatore, R Galiero, A Caturano, E Vetrano… - Biomolecules, 2021 - mdpi.com
Type 2 diabetes mellitus (T2DM) is a worldwide major health burden and heart failure (HF)
is the most common cardiovascular (CV) complication in affected patients. Therefore …

[HTML][HTML] Cardiovascular complications of diabetes: from microvascular to macrovascular pathways

M Zakir, N Ahuja, MA Surksha, R Sachdev, Y Kalariya… - Cureus, 2023 - ncbi.nlm.nih.gov
Diabetes mellitus, with a growing risk of develo** complications, has a significant negative
impact on cardiovascular health, including microvascular and macrovascular issues. This …

Can metformin exert as an active drug on endothelial dysfunction in diabetic subjects?

T Salvatore, PC Pafundi, R Galiero, L Rinaldi… - Biomedicines, 2020 - mdpi.com
Cardiovascular mortality is a major cause of death among in type 2 diabetes (T2DM).
Endothelial dysfunction (ED) is a well-known important risk factor for the development of …

ANGPTL3 inhibition, dyslipidemia, and cardiovascular diseases

F Luo, A Das, SA Khetarpal, Z Fang, TA Zelniker… - Trends in …, 2024 - Elsevier
Optimal management of low-density lipoprotein cholesterol (LDL-C) is a central tenet in the
primary and secondary prevention of atherosclerotic cardiovascular disease (ASCVD) …

Insulin: too much of a good thing is bad

H Kolb, K Kempf, M Röhling, S Martin - BMC medicine, 2020 - Springer
Background Insulin shares a limited physiological concentration range with other endocrine
hormones. Not only too low, but also too high systemic insulin levels are detrimental for body …

An Antibacterial and Anti‐Oxidative Hydrogel Dressing for Promoting Diabetic Wound Healing and Real‐Time Monitoring Wound pH Conditions with a NIR …

Y Zong, B Zong, R Zha, Y Zhang, X Li… - Advanced …, 2023 - Wiley Online Library
The design and synthesis of multifunctional chitosan hydrogels based on polymerized ionic
liquid and a near‐infrared (NIR) fluorescent probe (PIL‐CS) is a promising strategy, which …

Protective effects of metformin in various cardiovascular diseases: clinical evidence and AMPK‐dependent mechanisms

Y Bu, M Peng, X Tang, X Xu, Y Wu… - Journal of Cellular …, 2022 - Wiley Online Library
Metformin, a well‐known AMPK agonist, has been widely used as the first‐line drug for
treating type 2 diabetes. There had been a significant concern regarding the use of …